Cefilab 250mg/125mg Injection
Marketer
Medsyn Lab Biotech
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Cefilab 250mg/125mg Injection
Ceftriaxone/Sulbactam 250mg/125mg injection is a dual-action antibiotic. It's used to combat diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be overseen by a physician. Consistent adherence to the prescribed dosage schedule is crucial; incomplete treatment can compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require prompt emergency care. Inform your doctor of all current medications, and pregnant or lactating individuals should seek medical counsel before use. Alcohol should be avoided due to potential increased sedation. While generally non-impairing to driving ability, drowsiness or dizziness necessitates driving cessation. Sufficient rest, a nutritious diet, and adequate hydration promote faster recovery. Monitoring may involve laboratory tests to assess treatment response.
Uses of Cefilab 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Cefilab 250mg/125mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cefilab 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefilab 250mg/125mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cefilab 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Cefilab 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. The addition of Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Cefilab 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefilab, at a dosage of 250mg/125mg, is typically deemed safe for use in pregnancy. Preclinical trials in animals have revealed minimal or no harmful effects on fetal development; nevertheless, data from human clinical trials remain scarce.
Breast feedingCAUTION
Administering Cefilab 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefilab 250mg/125mg Injection might induce drowsiness, visual disturbances, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Cefilab 250mg/125mg Injection's use in patients with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Cefilab 250mg/125mg Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. Dosage alterations for Cefilab 250mg/125mg Injection are unnecessary in individuals with mild to moderate liver dysfunction.
What if you forget to take Cefilab 250mg/125mg Injection :
Should you inadvertently omit a dose of Cefilab 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Cefilab 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently